Convection-enhanced delivery of nanodiamond drug delivery platforms for intracranial tumor treatment

Guifa Xi*, Erik Robinson, Barbara Mania-Farnell, Elio Fausto Vanin, Kyu Won Shim, Tsurubuchi Takao, Elise Victoria Allender, Chandra Shekhar Mayanil, Marcelo Bento Soares, Dean Ho, Tadanori Tomita

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

94 Scopus citations


This study examined a novel drug delivery system for treatment of malignant brain gliomas: DOX complexed with nanodiamonds (ND-Dox), and administered via convection-enhanced delivery (CED). Drug retention and toxicity were examined in glioma cell lines, and distribution, retention and toxicity were examined in normal rat parenchyma. Efficacy was assessed in a bioluminescence rodent tumor model. NDs markedly enhanced DOX uptake and retention in glioma cells. ND-Dox delivered via CED extended DOX retention and localized DOX toxicity in normal rodent parenchyma, and was significantly more efficient at killing tumor cells than uncomplexed DOX. Outcomes from this work suggest that CED of ND-Dox is a promising approach for brain tumor treatment. From the Clinical Editor: In this paper, nanodiamonds were utilized to enhance delivery of DOX in a preclinical glioma model using a convection-enhanced delivery method, demonstrating remarkably enhanced efficacy.

Original languageEnglish (US)
Pages (from-to)381-391
Number of pages11
JournalNanomedicine: Nanotechnology, Biology, and Medicine
Issue number2
StatePublished - Feb 2014


  • Convection-enhanced delivery (CED)
  • Doxorubicin (Dox)
  • Glioma
  • Nanodiamonds (NDs)

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Molecular Medicine
  • Biomedical Engineering
  • Materials Science(all)
  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'Convection-enhanced delivery of nanodiamond drug delivery platforms for intracranial tumor treatment'. Together they form a unique fingerprint.

Cite this